There's Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative Diseases

Trends in Neurosciences

Volumn 39, Issue 3, 2016, Pages 146-157

  Paillusson, Sebastien ^a   Stoica, Radu ^a   Gomez Suaga, Patricia ^a   Lau, Dawn H W ^a   Mueller, Sarah ^a   Miller, Tanya ^b   Miller, Christopher C J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis fronto temporal dementia; Endoplasmic reticulum; Mitochondria; Mitochondria associated ER membranes; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; CALCIUM; INFLAMMASOME; PARKIN; PHOSPHOLIPID; PROTEIN; PROTEIN DEGLYCASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; CALCIUM TRANSPORT; DEGENERATIVE DISEASE; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; FRONTOTEMPORAL DEMENTIA; HUMAN; INTRACELLULAR TRANSPORT; MITOCHONDRIAL BIOGENESIS; MITOCHONDRION; NONHUMAN; PARKINSON DISEASE; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; REVIEW; UNFOLDED PROTEIN RESPONSE; ANIMAL; GENETICS; METABOLISM; NEURODEGENERATIVE DISEASES; PATHOLOGY; ULTRASTRUCTURE;

ANIMALS; ENDOPLASMIC RETICULUM; HUMANS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES;

EID: 84959129024     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2016.01.008     Document Type: Review

References (87)

1. Ling S.C., et al. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 2013, 79:416-438.
2. Goedert M., Spillantini M.G. A century of Alzheimer's disease. Science 2006, 314:777-781.
3. Hardy J. A hundred years of Alzheimer's disease research. Neuron 2006, 52:3-13.
4. Cookson M.R., Bandmann O. Parkinson's disease: insights from pathways. Hum. Mol. Genet. 2010, 19:R21-R27.
5. Harris H., Rubinsztein D.C. Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 2011, 8:108-117.
6. Johri A., Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. J. Pharmacol. Exp. Ther. 2012, 342:619-630.
7. Millecamps S., Julien J.P. Axonal transport deficits and neurodegenerative diseases. Nat. Rev. Neurosci. 2013, 14:161-176.
8. Roussel B.D., et al. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol. 2013, 12:105-118.
9. Bernales S., et al. Unfolded protein stress in the endoplasmic reticulum and mitochondria: a role in neurodegeneration. Front. Aging Neurosci. 2012, 4:5.
10. Martin M.G., et al. Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep. 2014, 15:1036-1052.
11. Schmitt F., et al. A plural role for lipids in motor neuron diseases: energy, signaling and structure. Front. Cell. Neurosci. 2014, 8:25.
12. Stutzmann G.E., Mattson M.P. Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease. Pharmacol. Rev. 2011, 63:700-727.
13. Ferraiuolo L., et al. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011, 7:616-630.
14. Glass C.K., et al. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934.
15. Hunn B.H., et al. Impaired intracellular trafficking defines early Parkinson's disease. Trends Neurosci. 2015, 38:178-188.
16. Gibbs K.L., et al. Regulation of axonal transport by protein kinases. Trends Biochem. Sci. 2015, 40:597-610.
17. Herrup K. The case for rejecting the amyloid cascade hypothesis. Nat. Neurosci. 2015, 18:794-799.
18. Csordas G., et al. Structural and functional features and significance of the physical linkage between ER and mitochondria. J. Cell Biol. 2006, 174:915-921.
19. Rowland A.A., Voeltz G.K. Endoplasmic reticulum-mitochondria contacts: function of the junction. Nat. Rev. Mol. Cell Biol. 2012, 13:607-625.
20. van Vliet A., et al. New functions of mitochondria associated membranes in cellular signalling. Biochim. Biophys. Acta 2014, 1843:2253-2262.
21. Helle S.C., et al. Organization and function of membrane contact sites. Biochim. Biophys. Acta 2013, 1833:2526-2541.
22. Area-Gomez E., et al. Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO. J. 2012, 31:4106-4123.
23. Wozniak M.J., et al. Role of kinesin-1 and cytoplasmic dynein in endoplasmic reticulum movement in VERO cells. J. Cell Sci. 2009, 122:1979-1989.
24. Saxton W.M., Hollenbeck P.J. The axonal transport of mitochondria. J. Cell Sci. 2012, 125:2095-2104.
25. Macaskill A.F., et al. Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 2009, 61:541-555.
26. Saotome M., et al. Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20728-20733.
27. Wang X., Schwarz T.L. The mechanism of Ca2+ -dependent regulation of kinesin-mediated mitochondrial motility. Cell 2009, 136:163-174.
28. Friedman J.R., et al. ER sliding dynamics and ER-mitochondrial contacts occur on acetylated microtubules. J. Cell Biol. 2010, 190:363-375.
29. Kornmann B., et al. The conserved GTPase Gem1 regulates endoplasmic reticulum-mitochondria connections. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:14151-14156.
30. de Brito O.M., Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008, 456:605-610.
31. De Vos K.J., et al. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum. Mol. Genet. 2012, 21:1299-1311.
32. Stoica R., et al. ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat. Commun. 2014, 5:3996.
33. Gkogkas C., et al. VAPB interacts with and modulates the activity of ATF6. Hum. Mol. Genet. 2008, 17:1517-1526.
34. Kanekura K., et al. Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8). J. Biol. Chem. 2006, 28:30223-30232.
35. Munoz J.P., et al. Mfn2 modulates the UPR and mitochondrial function via repression of PERK. EMBO J. 2013, 32:2348-2361.
36. Hayashi T., et al. MAM: more than just a housekeeper. Trends Cell Biol. 2009, 19:81-88.
37. Simmen T., et al. PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis. EMBO J. 2005, 24:717-729.
38. Hamasaki M., et al. Autophagosomes form at ER-mitochondria contact sites. Nature 2013, 495:389-393.
39. Korobova F., et al. An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2. Science 2013, 339:464-467.
40. Friedman J.R., et al. ER tubules mark sites of mitochondrial division. Science 2011, 334:358-362.
41. Gross O., et al. The inflammasome: an integrated view. Immunol. Rev. 2011, 243:136-151.
42. Zhou R., et al. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
43. Kornmann B., et al. An ER-mitochondria tethering complex revealed by a synthetic biology screen. Science 2009, 325:477-481.
44. Rapizzi E., et al. Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria. J. Cell Biol. 2002, 159:613-624.
45. Szabadkai G., et al. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J. Cell Biol. 2006, 175:901-911.
46. Cosson P., et al. Mitofusin-2 independent juxtaposition of endoplasmic reticulum and mitochondria: an ultrastructural study. PLoS ONE 2012, 7:e46293.
47. Filadi R., et al. Mitofusin 2 ablation increases endoplasmic reticulum-mitochondria coupling. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:E2174-E2181.
48. Wang P.T., et al. Distinct mechanisms controlling rough and smooth endoplasmic reticulum-mitochondria contacts. J. Cell Sci. 2015, 128:2759-2765.
49. Huttlin E.L., et al. The BioPlex network: a systematic exploration of the human interactome. Cell 2015, 162:425-440.
50. Iwasawa R., et al. Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction. EMBO J. 2011, 30:556-558.
51. Guardia-Laguarta C., et al. alpha-Synuclein is localized to mitochondria-associated ER membranes. J. Neurosci. 2014, 34:249-259.
52. Ottolini D., et al. The Parkinson disease related protein DJ-1 counteracts mitochondrial impairment induced by the tumor suppressor protein p53 by enhancing endoplasmic reticulum-mitochondria tethering. Hum. Mol. Genet. 2013, 22:2152-2168.
53. Cali T., et al. Alpha-synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions. J. Biol. Chem. 2012, 287:17914-17929.
54. Cali T., et al. Enhanced parkin levels favor ER-mitochondria crosstalk and guarantee Ca(2+) transfer to sustain cell bioenergetics. Biochim. Biophys. Acta 2013, 1832:495-508.
55. Hedskog L., et al. Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:7916-7921.
56. Zampese E., et al. Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2777-2782.
57. Area-Gomez E., et al. Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. Am. J. Pathol. 2009, 175:1810-1816.
58. Bernard-Marissal N., et al. Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration. Brain 2015, 138:875-890.
59. Lim Y., et al. Hereditary spastic paraplegia-linked REEP1 modulates endoplasmic reticulum/mitochondria contacts. Ann. Neurol. 2015, 78:679-696.
60. Tambini M.D., et al. ApoE4 upregulates the activity of mitochondria-associated ER membranes. EMBO Rep. 2015, 17:27-36.
61. De Strooper B. Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep. 2007, 8:141-146.
62. Sepulveda-Falla D., et al. Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis. J. Clin. Invest. 2014, 124:1552-1567.
63. Schreiner B., et al. Amyloid-beta peptides are generated in mitochondria-associated endoplasmic reticulum membranes. J. Alzheimers Dis. 2015, 43:369-374.
64. Liu C.C., et al. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 2013, 9:106-118.
65. Tsao W., et al. Rodent models of TDP-43: recent advances. Brain Res. 2012, 1462:26-39.
66. Gitcho M.A., et al. TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy. Acta Neuropathol. 2009, 118:633-645.
67. Nakamura K., et al. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J. Biol. Chem. 2011, 286:20710-20726.
68. De Vos K.J., et al. Role of axonal transport in neurodegenerative diseases. Annu. Rev. Neurosci. 2008, 31:151-173.
69. Eckert A., et al. Convergence of amyloid-beta and tau pathologies on mitochondria in vivo. Mol. Neurobiol. 2010, 41:107-114.
70. Le Masson G., et al. A computational model of motor neuron degeneration. Neuron 2014, 83:975-988.
71. Sugiura A., et al. MITOL Regulates endoplasmic reticulum-mitochondria contacts via Mitofusin2. Mol. Cell 2013, 51:20-34.
72. Ambegaokar S.S., Jackson G.R. Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation. Hum. Mol. Genet. 2011, 20:4947-4977.
73. Sreedharan J., et al. Age-dependent TDP-43-mediated motor neuron degeneration requires GSK3, hat-trick, and xmas-2. Curr. Biol. 2015, 25:2130-2136.
74. Moujalled D., et al. Kinase inhibitor screening identifies cyclin-dependent kinases and glycogen synthase kinase 3 as potential modulators of TDP-43 cytosolic accumulation during cell stress. PLoS ONE 2013, 8:e67433.
75. Llorens-Martin M., et al. GSK-3beta, a pivotal kinase in Alzheimer disease. Front. Mol. Neurosci. 2014, 7:46.
76. Golpich M., et al. Glycogen synthase kinase-3 beta (GSK-3beta) signaling: implications for Parkinson's disease. Pharmacol. Res. 2015, 97:16-26.
77. Poulopoulos M., et al. The neuropathology of genetic Parkinson's disease. Mov. Disord. 2012, 27:831-842.
78. Lin C.H., et al. LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3beta. J. Neurosci. 2010, 30:13138-13149.
79. Kawakami F., et al. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3beta. FEBS J. 2014, 281:3-13.
80. Sancho R.M., et al. Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways. Hum. Mol. Genet. 2009, 18:3955-3968.
81. Lidke D.S., Lidke K.A. Advances in high-resolution imaging: techniques for three-dimensional imaging of cellular structures. J. Cell Sci. 2012, 125:2571-2580.
82. Hirano Y., et al. Recent advancements in structured-illumination microscopy toward live-cell imaging. Microscopy 2015, 64:237-249.
83. Fornasiero E.F., Opazo F. Super-resolution imaging for cell biologists: concepts, applications, current challenges and developments. Bioessays 2015, 37:436-451.
84. Shim S.H., et al. Super-resolution fluorescence imaging of organelles in live cells with photoswitchable membrane probes. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:13978-13983.
85. Soderberg O., et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 2006, 3:995-1000.
86. Alford S.C., et al. Dimerization-dependent green and yellow fluorescent proteins. ACS Synth. Biol. 2012, 1:569-575.
87. Csordas G., et al. Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. Mol. Cell 2010, 39:121-132.